Cite
HARVARD Citation
Allanore, Y. et al. (2022). Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON. Annals of the rheumatic diseases. 81 (12), pp. 1722-1729. [Online].